Acurion, Inc.

Acurion is revolutionizing frontline cancer care by equipping oncologists with critical genomic activity insights to get cancer patients onto the right treatments faster. The company's mission is to accelerate the translation of its life-saving AI technology into the clinical arena to make a real, immediate and profound difference in therapy for patients worldwide.

Dedicated to improving patient outcomes, Acurion collaborates with leading research institutions, patient advocacy groups, and industry partners to advance precision oncology. Please visit www.acurionhealth.com to learn more.